Pathogenesis of NAFLD and NASH

Oct 6, 2016 by in GASTROENTEROLOGY Comments Off on Pathogenesis of NAFLD and NASH

Fig. 4.1 Adipocyte dysfunction in obesity . Adipocytes hypertrophy and enlarge during obesity. This can lead to an imbalance between blood flow and oxygen demand, resulting in hypoxia and cell…

read more

Pathogenesis of Alcoholic Liver Disease

Oct 6, 2016 by in GASTROENTEROLOGY Comments Off on Pathogenesis of Alcoholic Liver Disease

Fig. 3.1 Effects of heavy alcohol use on metabolic and signaling pathways leading to increased hepatic fat synthesis. Heavy alcohol use increases hepatic triglyceride content via increased uptake of fatty…

read more

Current and Emerging Therapies for Nonalcoholic Fatty Liver Disease

Oct 6, 2016 by in GASTROENTEROLOGY Comments Off on Current and Emerging Therapies for Nonalcoholic Fatty Liver Disease

Variables Overall n = 293 WL < 5 % n = 205 WL = 5–6.99 % n = 34 WL = 7–9.99 % n = 25 WL ≥ 10 % n = 29 P value** Weight loss (%) 3.8 ± 2.7 1.78 ± 0.16 5.86 ± 0.09 8.16 ± 0.22 13.04 ± 6.6 – Resolution of steatohepatitisa 72…

read more

Treatment of Alcoholic Liver Disease Including Emerging Therapies, Novel Targets, and Liver Transplantation

Oct 6, 2016 by in GASTROENTEROLOGY Comments Off on Treatment of Alcoholic Liver Disease Including Emerging Therapies, Novel Targets, and Liver Transplantation

Energy 25–40 kcal/kg/day, with extra 10 % in patients with ascites Carbohydrate • 50–60 % of total calories • Blood glucose monitoring recommended especially in patients treated with corticosteroids Protein…

read more
Get Clinical Tree app for offline access